Vezir, D. Et Al. 2022. Does preexisting immuncompromised status prevent mortality in COVID-19 patients: friend or foe?. EUROPEAN RESPIRATORY JOURNAL , vol.60 .

Vezir, D., Yildizeli, S. O., KOCAKAYA, D., Mercanci, Z., Balcan, B., Cinar, C., ... Eryuksel, E.(2022). Does preexisting immuncompromised status prevent mortality in COVID-19 patients: friend or foe?. EUROPEAN RESPIRATORY JOURNAL , vol.60.

Vezir, DUYGU Et Al. "Does preexisting immuncompromised status prevent mortality in COVID-19 patients: friend or foe?," EUROPEAN RESPIRATORY JOURNAL , vol.60, 2022

Vezir, DUYGU Et Al. "Does preexisting immuncompromised status prevent mortality in COVID-19 patients: friend or foe?." EUROPEAN RESPIRATORY JOURNAL , vol.60, 2022

Vezir, D. Et Al. (2022) . "Does preexisting immuncompromised status prevent mortality in COVID-19 patients: friend or foe?." EUROPEAN RESPIRATORY JOURNAL , vol.60.

@article{article, author={DUYGU VEZİR Et Al. }, title={Does preexisting immuncompromised status prevent mortality in COVID-19 patients: friend or foe?}, journal={EUROPEAN RESPIRATORY JOURNAL}, year=2022}